BioCardia (BCDA) CEO Peter Altman Buys 500 Shares

What Happened
Peter Altman, President, Chief Executive Officer and a director of BioCardia, purchased 500 shares of BCDA on 2026-07-17 at $0.83 per share, for a total reported outlay of $415. The transaction is reported on a Form 4 and coded as a purchase (P), indicating an acquisition rather than a sale.

Key Details

• Transaction date: 2026-07-17; Filing date (Form 4): 2026-07-20. Filing appears timely.
• Price and amount: 500 shares at $0.83/share; total value $415.
• Transaction type: Purchase (Form 4 code P) — listed as open-market or private purchase on the filing.
• Shares owned after transaction: Not specified in the reported data.
• Footnotes/plans: No 10b5-1 plan, tax-withholding, or other special footnotes indicated in the filing.

Context

• Small purchases like this ($415) are factual insider buys but are modest in size and may not indicate a material change in insider conviction. Purchases are generally more informative than sales, but motivation is not disclosed.
• The filing shows a straightforward purchase; there are no derivatives, exercises, gifts, or cashless transactions involved.